Core Viewpoint - Berger Montague PC is investigating potential securities law violations involving RxSight, Inc. following a class action lawsuit filed on behalf of investors who acquired RxSight securities during the specified Class Period [1][2]. Company Overview - RxSight, headquartered in Aliso Viejo, CA, is a medical technology company that develops light adjustable intraocular lenses (LAL) used in cataract surgery [2]. Legal Allegations - The lawsuit alleges that RxSight failed to disclose significant issues, including: 1. Adoption challenges and structural issues leading to declines in sales and utilization [3]. 2. Overstated demand for RxSight's products [3]. 3. Unlikelihood of meeting previously issued financial guidance for fiscal year 2025 [3]. Financial Impact - On July 8, 2025, RxSight reported significant declines in LDD sales, LAL utilization, and overall revenue for Q2 2025, subsequently lowering its full-year 2025 revenue guidance. CEO Ronald Kurtz attributed the decline to adoption challenges [4]. - Following this announcement, RxSight shares fell by $4.84, or 37%, closing at $7.95 per share on July 9, 2025 [4].

NEW YORK, July 31, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of 3D Systems Corporation (NYSE: DDD). WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. T ...

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of XPLR Infrastructure, LP (formerly Nextera Energy Partners, LP), encouraging them to contact the firm regarding potential lead plaintiff appointments in a class action lawsuit due to alleged misleading statements and operational struggles during a specified class period [1][3]. Summary by Relevant Sections Class Period and Allegations - The class period for the lawsuit is from September 27, 2023, to January 27, 2025 [3]. - Allegations include that XPLR was struggling to maintain operations as a yieldco and that the defendants issued materially false and misleading statements while downplaying risks associated with certain financing arrangements [3]. - It is claimed that XPLR could not resolve financing issues before maturity without risking significant unitholder dilution, leading to a planned halt in cash distributions to investors [3]. - The sustainability of XPLR's yieldco business model and distribution growth rate is questioned, with assertions that public statements made by the defendants were misleading throughout the relevant period [3]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by September 8, 2025, to participate in the case without any cost or obligation [4]. - Upon registration, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case's status [4]. Law Firm's Mission - The Gross Law Firm aims to protect the rights of investors affected by deceit and illegal business practices, emphasizing the importance of responsible corporate behavior [5].

Core Viewpoint - Berger Montague PC is investigating potential securities law violations involving RxSight, Inc. following a class action lawsuit filed on behalf of investors who acquired RxSight securities during the specified class period [1][2]. Company Overview - RxSight, Inc. is a medical technology company based in Aliso Viejo, CA, specializing in light adjustable intraocular lenses (LAL) used in cataract surgery, with its system involving the Light Delivery Device (LDD) [2]. Legal Allegations - The lawsuit alleges that RxSight's management failed to disclose significant issues, including: 1. Adoption challenges and structural issues leading to declines in sales and utilization [3]. 2. Overstated demand for RxSight's products [3]. 3. Unlikelihood of meeting previously issued financial guidance for fiscal year 2025 [3]. Financial Impact - On July 8, 2025, RxSight reported significant declines in LDD sales, LAL utilization, and overall revenue for Q2 2025, subsequently lowering its full-year 2025 revenue guidance. CEO Ronald Kurtz attributed the sales stall to adoption challenges over recent quarters [4]. - Following this announcement, RxSight shares fell by $4.84, or 37%, closing at $7.95 per share on July 9, 2025 [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Fortrea Holdings Inc. regarding a class action lawsuit alleging that the company made materially false and misleading statements about its financial prospects and business model during the specified class period [1][2]. Group 1: Allegations - The complaint alleges that Fortrea overestimated the revenue contributions from its long-term projects, known as the Pre-Spin Projects, to its 2025 earnings [1]. - It is claimed that Fortrea overstated the cost savings expected from exiting transition services agreements [1]. - The company's previously announced EBITDA targets for 2025 were allegedly inflated due to these misrepresentations [1]. - The viability of Fortrea's post-spin-off business model and its financial prospects were reportedly overstated [1]. - Consequently, the company's public statements were materially false and misleading throughout the relevant period [1]. Group 2: Class Action Details - The class period for the lawsuit is defined as July 3, 2023, to February 28, 2025 [1]. - Shareholders are encouraged to register for the class action by the deadline of August 1, 2025, to potentially be appointed as lead plaintiffs [2]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].

Core Viewpoint - The Schall Law Firm is investigating Proficient Auto Logistics, Inc. for potential violations of securities laws related to misleading statements and undisclosed information affecting investors [1][2]. Group 1: Investigation Details - The investigation centers on whether Proficient Auto issued false or misleading statements and failed to disclose relevant information to investors [2]. - Following the announcement of Q1 financial results on May 7, 2025, Proficient Auto reported a decline in year-over-year total operating revenue and a net operating loss [2]. - As a result of the negative financial news, Proficient Auto's shares fell by more than 4.9% the following day [2]. Group 2: Legal Representation - The Schall Law Firm offers free consultations for shareholders who may have suffered losses due to the company's actions [3]. - The firm specializes in securities class action lawsuits and shareholder rights litigation, representing investors globally [3].

Core Viewpoint - Rowley Law PLLC is investigating potential securities law violations related to the proposed acquisition of Veritex Holdings, Inc. by Huntington Bancshares Incorporated, which is valued at approximately $1.9 billion [1]. Group 1: Acquisition Details - The proposed acquisition involves stockholders of Veritex Holdings receiving 1.95 shares of Huntington Bancshares common stock for each share of Veritex Holdings stock they hold [1]. - The transaction is expected to close in the fourth quarter of 2025 [1]. Group 2: Legal Investigation - Rowley Law PLLC is representing shareholders in the investigation concerning the acquisition and potential securities law violations by Veritex Holdings and its board of directors [1]. - Additional information regarding the investigation can be obtained by contacting Rowley Law PLLC [2].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Reckitt Benckiser Group plc regarding a class action lawsuit related to misleading statements and omissions concerning the safety of its Enfamil formula for preterm infants [1][3]. Group 1: Allegations and Class Period - The class period for the lawsuit is defined as January 13, 2021, to July 28, 2024 [3]. - Allegations include that Reckitt's cow's milk-based formula, Enfamil, posed an increased risk of necrotizing enterocolitis (NEC) in preterm infants, which was not disclosed [3]. - The lawsuit claims that Reckitt's positive statements about its business and operations were materially false and misleading due to the undisclosed risks and potential legal claims [3]. Group 2: Shareholder Actions and Deadlines - Shareholders are encouraged to register for the class action by August 4, 2025, to participate in potential recovery [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [4]. - There is no cost or obligation for shareholders to participate in the case [4]. Group 3: Law Firm's Mission - The Gross Law Firm aims to protect investors' rights who have suffered losses due to deceit and illegal business practices [5]. - The firm emphasizes the importance of responsible business practices and corporate citizenship [5]. - The firm seeks recovery for investors affected by misleading statements that led to artificial inflation of the company's stock [5].

Core Viewpoint - Berger Montague is investigating potential securities law violations involving Petco Health and Wellness Company, Inc., following a class action lawsuit filed on behalf of investors who acquired Petco securities between January 14, 2021, and June 5, 2025 [1][2] Group 1: Legal Investigation - A class action lawsuit has been initiated against Petco, with a deadline for investors to seek lead plaintiff status by August 29, 2025 [2] - The lawsuit alleges that Petco made materially false and misleading statements regarding its pandemic-related growth and the sustainability of its premium pet food business model [3] Group 2: Financial Impact - The complaint claims that these misrepresentations led to significant declines in Petco's stock price, including a drop of over 20% on August 24, 2023, following a downward revision of financial guidance [3]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Compass Group Diversified Holdings, LLC (NYSE: CODI) regarding a class action lawsuit due to alleged failures in financial reporting and internal controls [1][3]. Summary by Relevant Sections Allegations - The complaint alleges that Compass failed to disclose effective internal controls over financial reporting and critical information regarding its subsidiary, Lugano Holding, Inc. This included undisclosed financing arrangements and irregularities in sales, cost of sales, inventory, and accounts receivable [3]. - The truth about these issues emerged on May 7, 2025, when Compass announced that its financial statements for fiscal 2024 could no longer be relied upon due to an internal investigation into Lugano [3]. - Following this announcement, Compass's stock price plummeted from $17.25 per share on May 7, 2025, to $6.55 per share on May 8, 2025 [3]. Next Steps for Shareholders - Shareholders who purchased shares of CODI during the class period (February 24, 2022, to May 7, 2025) are encouraged to register for the class action by July 8, 2025 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates throughout the case [4]. Law Firm's Commitment - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors who have suffered due to deceit, fraud, and illegal business practices [5]. - The firm aims to ensure that companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements or omissions that led to stock inflation [5].